ULK3 Antikörper (Middle Region)
Kurzübersicht für ULK3 Antikörper (Middle Region) (ABIN2787898)
Target
Alle ULK3 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Middle Region
-
Sequenz
- LGRATALVVQ AVKKDQEGDS AAALSLYCKA LDFFVPALHY EVDAQRKEAI
-
Homologie
- Cow: 93%, Dog: 86%, Guinea Pig: 79%, Horse: 93%, Human: 100%, Mouse: 86%, Pig: 86%, Rabbit: 86%, Rat: 86%
-
Produktmerkmale
- This is a rabbit polyclonal antibody against ULK3. It was validated on Western Blot.
-
Aufreinigung
- Affinity Purified
-
Immunogen
- The immunogen is a synthetic peptide directed towards the middle region of human ULK3
-
-
-
-
Applikationshinweise
- Optimal working dilutions should be determined experimentally by the investigator.
-
Kommentare
-
Antigen size: 472 AA
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
- ULK3 (Unc-51-Like Kinase 3 (ULK3))
-
Andere Bezeichnung
- ULK3
-
Hintergrund
-
ULK3 is the serine/threonine protein kinase which enhances GLI1 and GLI2 transcriptional activity and consequently positively regulates GLI-dependent SHH signaling. ULK3 may exert this function by promoting GLI1 nuclear localization. ULK3 phosphorylates in vitro GLI2, as well as GLI1 and GLI3, although less efficiently.
Alias Symbols: DKFZp434C131, FLJ90566
Protein Interaction Partner: VCP, WDR82, UBC,
Protein Size: 472 -
Molekulargewicht
- 53 kDa
-
Gen-ID
- 25989
-
NCBI Accession
- NM_001099436, NP_001092906
-
UniProt
- Q6PHR2
Target
-